| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.3B | — | $1.5B | — | -14.1% |
| Op. Income | $46M | — | $255M | — | -82.1% |
| Gross Margin | 97.9% | — | 97.0% | — | 0.9pp |
| Net Margin | 4.4% | — | 16.4% | — | -12.1pp |
| EPS (Diluted) | $1.08 | — | $4.79 | — | -77.5% |
| Free Cash Flow | -$91M | — | -$90M | — | -1.4% |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $28M |
| GROSS PROFIT | $1.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $66M |
| Other Expenses | $1.2B |
| Operating Expenses | $1.2B |
| Cost & Expenses | $1.3B |
| OPERATING INCOME | $46M |
| Interest Income | $18M |
| Interest Expense | $10M |
| Other Income/Expenses | $9M |
| INCOME BEFORE TAX | $54M |
| Income Tax Expense | -$3M |
| Net Income from Continuing Ops | $57M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $57M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $57M |
| D&A | $190M |
| EBIT | $46M |
| EBITDA | $236M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $28M |
| GROSS PROFIT | $1.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $66M |
| Other Expenses | $1.2B |
| Operating Expenses | $1.2B |
| Cost & Expenses | $1.3B |
| OPERATING INCOME | $46M |
| Interest Income | $18M |
| Interest Expense | $10M |
| Other Income/Expenses | $9M |
| INCOME BEFORE TAX | $54M |
| Income Tax Expense | -$3M |
| Net Income from Continuing Ops | $57M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $57M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $57M |
| D&A | $190M |
| EBIT | $46M |
| EBITDA | $236M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $57M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $20M |
| Deferred Income Tax | -$9M |
| Other Non-Cash Items | $190M |
| Change in Working Capital | -$30M |
| OPERATING CASH FLOW | $229M |
| Capital Expenditure | -$320M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $6M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$91M |
| NET CASH FROM INVESTING | -$405M |
| Net Debt Issuance | $12M |
| Common Stock Repurchased | -$9M |
| Common Dividends Paid | -$18M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$15M |
| FREE CASH FLOW | -$91M |
| Net Change in Cash | -$191M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $300M |
| Short-Term Investments | $53M |
| Net Receivables | $182M |
| Inventory | $236M |
| Other Current Assets | $49M |
| TOTAL CURRENT ASSETS | $820M |
| PP&E (Net) | $1.8B |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $8M |
| Tax Assets | $3M |
| Other Non-Current Assets | $135M |
| TOTAL NON-CURRENT ASSETS | $2.0B |
| TOTAL ASSETS | $2.8B |
| Account Payables | $66M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $152M |
| TOTAL CURRENT LIABILITIES | $257M |
| Long-Term Debt | $154M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $54M |
| Other Non-Current Liabilities | $99M |
| TOTAL NON-CURRENT LIABILITIES | $385M |
| TOTAL LIABILITIES | $642M |
| Common Stock | $548.0K |
| Additional Paid-In Capital | $301M |
| Retained Earnings | $1.9B |
| Treasury Stock | -$51M |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.1B |
| TOTAL LIABILITIES & EQUITY | $2.8B |
| Total Debt | $271M |
| Net Debt | -$29M |
